Bain Capital Life Sciences Fund II, L.P.

13F Holdings History for C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 6.06M shares
Security Ownership: 6.25%

BCLS II Equity Opportunities, LP ownership in C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

2025-10-24 - BCLS II Equity Opportunities, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.06M shares of C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC). This represents 6.25% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BCLS II Equity Opportunities, LP	6.25%		$13.5M	6.06M			$2.22	13G	10/17/2025	24 Oct 2025 16:30:06